Venture Center invests in neonatal care startup Sensivision Healthcare

Sensivision is a medical device startup focused on the critical care segment of Neonates, and Venture Center and CCAMP have collaborated to support the company in this round of investment

0
60
Download PDF

New Delhi: Technology startup incubator Venture Center has invested an undisclosed amount of seed funding in healthcare startup Sensivision Health under the NIDHI-SSS (National Initiative for Developing and Harnessing Innovations-Seed Support System), an umbrella programme of the Department of Science and Technology (DST) of Government of India.

Sensivision is a medical device startup focused on the critical care segment of Neonates, and Venture Center and CCAMP have collaborated to support the company in this round of investment.

Speaking on the development, Jayadeep Unni, founder Sensivision Health, said “Birth asphyxia is the cause of 23 percent of all neonatal deaths worldwide.  We are developing a device that is uniquely tailored for countries like India where a large number of babies affected with Hypoxic Ischemic Encephalopathy (HIE) go untreated. This investment will help us in our clinical investigations and commercialization of the device in the coming months.”

Hypoxic Ischemic Encephalopathy (HIE) results in babies either dying or developing brain damages resulting in life-long disabilities. Sensivision has developed a patented and first-of-its-kind integrated device to predict, monitor and treat HIE in new-borns. It is a portable cooling system with amplitude Integrated EEG for monitoring and prognosis. This device can be used in emergency cases where a newborn needs their body temperature to be regulated.

“Sensivision is a story of commitment, passion and sharp business focus of an experienced biomedical engineer returning from foreign shores to build something that can have very large and global social impact, especially for child health. The Venture Center investment committee noted the international interest in Sensivision’s product offerings and was very excited to be able to help Sensivision take their ideas to the next level. Sensivision is also a recipient of the Biotech Ignition grant from BIRAC, and has been mentored by Venture Center”, said Dr. Premnath, Director, Venture Center.

NIDHI-SSS (National Initiative for Developing and Harnessing Innovations-Seed Support System) is an umbrella program of the Department of Science and technology that provides financial assistance up to Rs. 1 Crore to potential startups with promising ideas, innovations and technologies. Venture Center has previously invested in two other healthcare start-ups under the NIDHI Seed Support System.

Founded in 2007, Venture Center is one of India’s leading science and technology business incubator that has supported over 350 entrepreneurs, and has incubated more than 70 startups. Venture Center won the National Award for Technology Business Incubators from the President of India in 2016, and was adjudged “Incubator of the Year” in 2018 by the Asian Association of Business Incubation.